EXPERIMENT X
LIVE

Serial Number

79287058

Owner

Experiment X Ltd

Attorney

Mark D. Simpson

Filing Date

Apr 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EXPERIMENT X Trademark

Serial Number: 79287058 • Registration: 6391815

EXPERIMENT X is a trademark filed by Experiment X Ltd on April 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Experiment X Ltd (2 trademarks)

4th Floor, Beaumont House,

Entity Type: 99

Trademark Details

Filing Date

April 9, 2020

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

Downloadable and recorded computer software for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; Downloadable and recorded computer software for machine learning or artificial intelligence based medical diagnostics; computer hardware for personal medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; downloadable mobile applications for personal medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; downloadable and recorded computer software for the control of medical apparatus, instruments, equipment and devices; downloadable and recorded computer software for the control of medical apparatus, instruments, equipment and devices, namely immunoassays, lateral flow immunoassays, multiplex immunoassays, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices

Diagnostic reagents for medical use; diagnostic reagents for medical use, namely, for screening testing, analyzing and monitoring of biological material; diagnostic reagents for medical use, namely, for immunoassays, lateral flow immunoassays, multiplex immunoassays, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices, polymerase chain reaction devices; diagnostic substances for medical use for sale in kit form; diagnostic scanning agents for in-vitro medical use; diagnostic testing reagents for testing of body fluids for medical use; diagnostic preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes

Medical apparatus, instruments, equipment and devices, namely devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely point-of-care devices for medical diagnostics, health tracking, telemedicine, telehealth, and for screening testing, analyzing and monitoring of biological material; medical apparatus, instruments, equipment and devices, namely, immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; medical testing kits, namely medical testing kits including immunoassays, lateral flow immunoassays, multiplex immunoassays, and microfluidics; diagnostic apparatus and instruments for screening testing, analyzing and monitoring of biological material

Software design and development; design and development of software for medical diagnostics, health tracking, telemedicine, telehealth; design and development of software for screening testing, analyzing and monitoring of biological material; design and development of software for immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; design and development of computer hardware; design and development of computer hardware for medical diagnostics, health tracking, telemedicine, telehealth; design and development of computer hardware for screening testing, analyzing and monitoring of biological material; design and development of computer hardware for immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; research, design, development, technological consultancy, and engineering services relating to medical apparatus, instruments, equipment and devices; research, design, development, technological consultancy, and engineering services relating to immunoassay readers, lateral flow immunoassay readers, multiplex immunoassay readers, microfluidic devices, blood counting devices, cytometric devices, electrochemistry devices and polymerase chain reaction devices; research, design, development, and technological consultancy services relating to biomarker discovery; providing temporary use of non-downloadable cloud accessible software for medical diagnostics, health tracking, telemedicine and telehealth; cloud computing services for medical diagnostics, health tracking, telemedicine, and telehealth

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 12, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 22, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 5, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 26, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 26, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 26, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 26, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 10, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 11, 2020 REPR